Thomas Liman
- Psychiatry and Mental health top 2%
- Neurological Complications and Syndromes 11
- Migraine and Headache Studies 7
- Dementia and Cognitive Impairment Research 5
- Rheumatology top 2%
- Moyamoya disease diagnosis and treatment 7
- Neurology top 5%
- Rehabilitation top 5%
- Stroke Rehabilitation and Recovery 5
- Obstetrics and Gynecology top 5%
-
- Acute Ischemic Stroke Management 13
-
- Cerebrovascular and Carotid Artery Diseases 6
-
- Pharmacological Effects and Toxicity Studies 6
- Co-authors
- Matthias EndresEberhard SiebertGeorg BöhnerPeter U. HeuschmannLars NeebBob SiegerinkUwe ReuterPeter L. Kolominsky‐Rabas
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Thomas Liman
55 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Psychiatry and Mental health 678
- Rheumatology 392
- Neurology 166
- Rehabilitation 131
- Obstetrics and Gynecology 149
Countries citing papers authored by Thomas Liman
This map shows the geographic impact of Thomas Liman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Liman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Liman more than expected).
Fields of papers citing papers by Thomas Liman
This network shows the impact of papers produced by Thomas Liman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Liman. The network helps show where Thomas Liman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Liman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 6 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 0 | |
| 5 | 2022 | 4 | |
| 6 | 2021 | 17 | |
| 7 | 2021 | 10 | |
| 8 | 2018 | 14 | |
| 9 | 2017 | 2 | |
| 10 | 2016 | 56 | |
| 11 | 2015 | 30 | |
| 12 | 2015 | 14 | |
| 13 | 2014 | 41 | |
| 14 | 2014 | 14 | |
| 15 | 2012 | 78 | |
| 16 | 2012 | 60 | |
| 17 | 2011 | 30 | |
| 18 | 2011 | 40 | |
| 19 | 2011 | 41 | |
| 20 | 2007 | 9 |
About Thomas Liman
Thomas Liman is a scholar working on Psychiatry and Mental health, Internal Medicine and Biological Psychiatry, having authored 60 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (13 papers), Neurological Complications and Syndromes (11 papers), Moyamoya disease diagnosis and treatment (7 papers), Migraine and Headache Studies (7 papers), Cerebrovascular and Carotid Artery Diseases (6 papers), Pharmacological Effects and Toxicity Studies (6 papers), Stroke Rehabilitation and Recovery (5 papers) and Dementia and Cognitive Impairment Research (5 papers). The work is most often cited by research in Psychiatry and Mental health (678 citations), Rheumatology (392 citations) and Neurology (166 citations). Thomas Liman has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Matthias Endres, Eberhard Siebert, Georg Böhner, Peter U. Heuschmann, Lars Neeb, Bob Siegerink, Uwe Reuter, Peter L. Kolominsky‐Rabas, Stefan Schwab and Nicolle Kränkel. Their work appears in journals such as Journal of Neurology, Stroke, Cerebrovascular Diseases, Frontiers in Neurology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.